-+ 0.00%
-+ 0.00%
-+ 0.00%

Bicara reports Phase 1b data for ficerafusp alfa 2000mg Q2W plus pembrolizumab in first-line HPV-negative R/M HNSCC

Reuters·02/19/2026 21:30:26

Please log in to view news